WallStreetZenWallStreetZen

NASDAQ: MRSN
Mersana Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Mersana Therapeutics earnings were -$74.0M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest MRSN earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$24.1M, up 70.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MRSN reported annual earnings of -$69.2M, with -59.7% growth.

MRSN earnings history

Current Revenue
$34.0M
Current Earnings
-$74.0M
Current Profit Margin
-217.6%

MRSN Return on Equity

Current Company
N/A
Current Industry
-60.5%
Current Market
28.6%

MRSN undefined

Current Company
-48.9%
Current Industry
-2%
MRSN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MRSN announces earnings.

MRSN undefined

Current Company
-128.79%
Current Industry
6.4%
MRSN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MRSN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MRSN-$65.21M-$74.01MN/A-$0.59
NRXP-$24.11M-$24.11MN/A-$2.01
AVTX$70.18M$73.01MN/A-$4.01
ATHEN/A-$12.45MN/A-$1.25
ANEB-$7.27M-$7.69MN/A-$0.26
View Top Biotech Stocks

Mersana Therapeutics Earnings Reports & History FAQ

What were Mersana Therapeutics's earnings last quarter?

On MRSN's earnings call on Invalid Date, Mersana Therapeutics (NASDAQ: MRSN) reported Q1 2025 earnings per share (EPS) of -$0.19, up 18.75% year over year. Total MRSN earnings for the quarter were -$24.12 million. In the same quarter last year, Mersana Therapeutics's earnings per share (EPS) was -$0.16.

If you're new to stock investing, here's how to buy Mersana Therapeutics stock.

Is Mersana Therapeutics profitable or losing money?

As of the last Mersana Therapeutics earnings report, Mersana Therapeutics is currently losing money. Mersana Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$74.01 million, a 45.1% decrease year over year.

What was MRSN's earnings growth in the past year?

As of Mersana Therapeutics's earnings date in Invalid Date, Mersana Therapeutics's earnings has grown year over year. MRSN earnings in the past year totalled -$74.01 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.